Yahoo Finance

Vector Institute announces nearly $2 million in scholarships for top Ontario AI graduate students

TORONTO, May 08, 2024 (GLOBE NEWSWIRE) -- Today, the Vector Institute announced the 115 recipients of the 2024-25 Vector Scholarship in Artificial Intelligence (VSAI). These $17,500 merit-based ...
GEN

ReiThera – GRAd-COV2

Type: Vaccine based on a novel and proprietary replication-defective simian (gorilla) adenoviral vector called GRAd, which encodes the full-length coronavirus spike protein. The GRAd vector belongs to ...
Yahoo Finance

ReiThera Srl, The Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation

ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd ...
Business Insider

ReiThera Announces its GRAd-COV2 COVID-19 Vaccine Candidate is Well Tolerated and Induces Clear Immune Responses in Healthy Subjects Aged 18-55 Years

Phase 1 Trial to Advance into Elderly Subjects Aged 65-85 Years ROME, Nov. 24, 2020 /PRNewswire/ -- ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and ...
GEN

ReiThera and Exothera Collaborate on Vaccine Manufacturing Process

ReiThera and Exothera entered into a collaboration agreement to develop a large-scale, low cost per dose manufacturing process for the production of ReiThera’s novel vaccines. The collaboration will ...
Pharmabiz

ReiThera, Ragon Institute of Mass General, MIT, and Harvard, & IAVI collaborate to advance highly networked T cell HIV vaccine candidate towards phase I clinical evaluation

ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd ...